Advertisement

Topics

After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering

06:05 EDT 17 May 2018 | Labiotech.eu

Cellectis spin-off Calyxt has launched a €41M follow-on round after settling the lawsuit it recently brought against Bayer CropScience, for breach of a license agreement for access to patents for its TALEN technology. The French biotech Cellectis owns 79.1% of the ag biotech’s ...

This awesome article After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering appeared first on Labiotech.eu. Be kind and don't copy it without asking ;)

Original Article: After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering

NEXT ARTICLE

More From BioPortfolio on "After settling lawsuit with Bayer, Cellectis spin-off launches €41M follow-on offering"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...